Epidemiology of perioperative anaphylaxis in France in 2017-2018: the 11th GERAP survey
Charles Tacquard,Julien Serrier,Simon Viville,Anca-Mirela Chiriac,Sébastien Franchina,Aurélie Gouel-Cheron,Antoine Giraudon,Morgan Le Guen,Diane Le Quang,Jean-Marc Malinovsky,Nadine Petitpain,Pascal Demoly,Paul M Mertes,GERAP study group,Morisset Martine,Husser Solène,Huyn Vinh An,Perquin Mélanie,Lakkis-Castelain Florence,Feesenmeyer Christine,Pellerin Christelle,Bordes-Demolis Marilyne,Giraudon Antoine,Vaia Elleni,Mariotte Delphine,Ollivier Yann,Serrier Julien,Dalampira Georgia,Muti Daniela,Baud Charlotte,Clermont Ferrand,Capo-Chichi Rosita,Seltzer Sandrine,Vandenbergue-Durr Sophie,Zambelli Valentina,Pottier Eloïse,Mear Amélie,Pouessel Guillaume,Facon Alain,Pelletier De Chambure Diane,Delebarre-Sauvage Christine,Caron Juliette,Bellet Elisabeth,Orsel Isabelle,Mullet Christelle,Diot-Junique Nathalie,Ferrenq-Dubost Rolande,Billard Carine,Lefervre Sébastien,Chiriac Anca,Demoly Pascal,Gouitaa Marion,Serrano Eva,Tezier Marie,Hassan El Hanache,Colas Luc,Aguinet Emmanuelle,Petit Isabelle,Rezzadori Gilles,Patel Minaxi,Miran Sophie,Merzouk Aïcha,Smilov Magdalena,Gouel-Cheron Aurélie,Neukirch Catherine,Karila-Beaulier Chantal,Lepage David,Seringulian Alice,Verdaguer Marion,Renauld Valérie,Malinovsky Jean-Marc,Rochefort-Morel Cécile,Dessard Sabrina,Lisa Le Guillou,Franchina Sébastien,Meunier Yannick,Girard Emmanuel,Nafeh Samer,Delzanno Cédric,Dzviga Charles,Stenger Rodolphe,Tacquard Charles,Mertes Paul-Michel,Gil Céline,Mailhol Claire,Migueres Isabelle,Hoarau Cyrille
DOI: https://doi.org/10.1016/j.bja.2024.01.044
Abstract:Background: Perioperative anaphylaxis is rare but is associated with significant morbidity. This complication has been well described in France by the GERAP (Groupe d'Etude des Réactions Anaphylactiques Périopératoires), a network focused on its study. The epidemiology of perioperative anaphylaxis is evolving, influenced by environmental factors and clinical practice. The aim of this study was to update the epidemiology of perioperative anaphylaxis in France. Methods: This multicentre retrospective study was performed in 26 allergy clinics of the GERAP network in 2017-8. Results: There were 765 patients with perioperative anaphylaxis included. Most cases were severe, with 428 (56%) reactions graded as 3 or 4 according to the Ring and Messmer classification. Skin test results were available for 676 patients, with a culprit agent identified in 471 cases (70%). Neuromuscular blocking agents were the main cause of perioperative anaphylaxis (n=281; 60%), followed by antibiotics (n=118; 25%) and patent blue dye (n=11; 2%). Cefazolin was the main antibiotic responsible for perioperative anaphylaxis (52% of antibiotic-related reactions). Suxamethonium and rocuronium were the main neuromuscular blocking agents responsible for perioperative anaphylaxis with 7.1 (6.1-8.4) and 5.6 (4.2-7.4) reactions per 100,000 vials sold, respectively, whereas cefazolin-related cases were estimated at 0.7 (0.5-0.9) reactions per 100,000 vials sold. Conclusions: Our results confirm that most commonly identified triggering agents remain neuromuscular blocking agents. Reactions to antibiotics, particularly cefazolin, are becoming increasingly frequent. The origin of sensitisation to cefazolin is unknown, as no cross-sensitisation has been described, and it should be the subject of further study. Perioperative anaphylaxis should be followed over the years and understood given the changing triggers. Clinical trial registration: ClinicalTrials.gov (NCT04654923).